Acorda Therapeutics, Inc. logo

Acorda Therapeutics, Inc. Share Price Today (NASDAQ: ACOR)

Acorda Therapeutics, Inc. share price is $0 & ₹0.00 as on 10 Apr 2024 IST

▲

-0.66

(-100%)

Market is closed - opens 7 PM, 15 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 11 Apr 2024

View live Acorda Therapeutics, Inc. share price in Dollar and Rupees. Guide to invest in Acorda Therapeutics, Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Acorda Therapeutics, Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Acorda Therapeutics, Inc. (ACOR) Key Statistics

in dollars & INR

Previous Close
$0.661
Open
$0.7838
Market Capitalization
$1.1M
Today's Volume
$414.1K
Revenue TTM
$111.1M
EBITDA
$11.5M
Earnings Per Share (EPS)
$2.61
PE Ratio
0.34
Profit Margin
-14.36%
Quarterly Earnings Growth YOY
5.87%
Return On Equity TTM
-23.68%

How to invest in Acorda Therapeutics, Inc. Stock (ACOR) from India?

It is very easy for Indian residents to invest directly in Acorda Therapeutics, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acorda Therapeutics, Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Acorda Therapeutics, Inc. or ACOR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acorda Therapeutics, Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acorda Therapeutics, Inc. shares which would translate to null fractional shares of Acorda Therapeutics, Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Acorda Therapeutics, Inc., in just a few clicks!

Global Institutional Holdings in Acorda Therapeutics, Inc.

  • Davidson Kempner Capital Management LP

    4.44%

  • Renaissance Technologies Corp

    3.68%

  • Acadian Asset Management LLC

    2.71%

  • Vanguard Group Inc

    0.86%

  • BlackRock Inc

    0.53%

  • Wells Fargo & Co

    0.30%

Analyst Recommendation on Acorda Therapeutics, Inc.

Rating
Trend

Buy

    100%Buy

    0%Hold

    0%Sell

Based on 1 Wall street analysts offering stock ratings for Acorda Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

About Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. The company's product pipeline includes Cimaglermin alfa (GGF2), a member of neuregulin growth factor family which is in Phase 1 clinical trials for recovery of neurological injury, as well as to enhance heart function in animal models of heart failure. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York.
Organization
Acorda Therapeutics, Inc.
Employees
111
CEO
Dr. Ron Cohen M.D.
Industry
Health Technology

Important FAQs about investing in ACOR Stock from India :

Can Indians buy Acorda Therapeutics, Inc. shares?

Yes, Indians can invest in the Acorda Therapeutics, Inc. (ACOR) from India.

With INDmoney, you can buy Acorda Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Acorda Therapeutics, Inc. at zero transaction cost.

How can I buy Acorda Therapeutics, Inc. shares from India?

It is very easy to buy Acorda Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acorda Therapeutics, Inc. (ACOR) be purchased?

Yes, you can buy fractional shares of Acorda Therapeutics, Inc. with INDmoney app.

What are the documents required to start investing in Acorda Therapeutics, Inc. stocks?

To start investing in Acorda Therapeutics, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Acorda Therapeutics, Inc.?

Today's market capitalisation of Acorda Therapeutics, Inc. ACOR is 1.1M

Who is the Chief Executive Officer (CEO) of Acorda Therapeutics, Inc. ?

Dr. Ron Cohen M.D. is the current Chief Executive Officer (CEO) of Acorda Therapeutics, Inc..